A Randomized Double-Blind, Placebo-Controlled, 4-Period Cross-Over Study to Assess the Effect of Single and Multiple Doses of 1.5 mg and 4.5 mg Org 50081 and a Single Dose of 7.5 mg Zopiclone on Next-Day Driving Ability and Psychomotor Performance in Healthy Volunteers.

Trial Profile

A Randomized Double-Blind, Placebo-Controlled, 4-Period Cross-Over Study to Assess the Effect of Single and Multiple Doses of 1.5 mg and 4.5 mg Org 50081 and a Single Dose of 7.5 mg Zopiclone on Next-Day Driving Ability and Psychomotor Performance in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Sep 2013

At a glance

  • Drugs Esmirtazapine; Zopiclone
  • Indications Mental disorders; Sleep disorders
  • Focus Pharmacodynamics
  • Sponsors Organon
  • Most Recent Events

    • 03 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top